{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:17:21Z","timestamp":1781842641259,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","award":["PI14\/01648"],"award-info":[{"award-number":["PI14\/01648"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","award":["CP13\/00070"],"award-info":[{"award-number":["CP13\/00070"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["20152431"],"award-info":[{"award-number":["20152431"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","award":["CP13\/00070"],"award-info":[{"award-number":["CP13\/00070"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.atherosclerosis.2019.01.036","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T16:11:13Z","timestamp":1549901473000},"page":"52-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients"],"prefix":"10.1016","volume":"283","author":[{"given":"Francisco","family":"Blanco-Vaca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0414-037X","authenticated-orcid":false,"given":"Jes\u00fas M.","family":"Martin-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Beteta-Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Canyelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Roig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Farr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-2246","authenticated-orcid":false,"given":"Josep","family":"Julve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0301-9984","authenticated-orcid":false,"given":"Mireia","family":"Tondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MOL.0000000000000072","article-title":"Hypobetalipoproteinemia and abetalipoproteinemia","volume":"25","author":"Welty","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2015.10.033","article-title":"Update on the molecular biology of dyslipidemias","volume":"454","author":"Ramasamy","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10545-013-9665-4","article-title":"Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management","volume":"37","author":"Lee","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib4","article-title":"Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia","author":"Tarugi","year":"2018","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5223\/pghn.2018.21.2.134","article-title":"Chylomicron retention disease: a description of a new mutation in a very rare disease","volume":"21","author":"Ferreira","year":"2018","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11883-014-0423-3","article-title":"Update on primary hypobetalipoproteinemia","volume":"16","author":"Hooper","year":"2014","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-Function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"J\u00f8rgensen","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib8","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/eurheartj\/ehs472","article-title":"Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein","volume":"34","author":"Sorrentino","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.bbalip.2011.08.010","article-title":"Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice","volume":"1811","author":"Chandak","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib10","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1056\/NEJMoa1405386","article-title":"Inactivating mutations in NPC1L1 and protection from coronary heart disease","volume":"371","author":"Stitziel","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1373\/clinchem.2014.231365","article-title":"Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries","volume":"61","author":"Futema","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib13","first-page":"730","article-title":"The lipid profile of Spanish population: the DRECE study (Diet and Risk of Cardiovascular Disease in Spain)","volume":"113","author":"G\u00f3mez-Gerique","year":"1999","journal-title":"Med. Clin. Barcelona"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib14","first-page":"195","article-title":"Serum levels of apolipoproteins A-I and B in a population sample of the Comunidad Valenciana: utility for assesment of cardiovascular risk","volume":"13","author":"Villar-Serrano","year":"2001","journal-title":"Cl\u00edn. Invest. Arterioscler."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib15","first-page":"115","article-title":"The Staden package, 1998","volume":"132","author":"Staden","year":"2000","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nprot.2015.123","article-title":"SIFT missense predictions for genomes","volume":"11","author":"Vaser","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib18","doi-asserted-by":"crossref","first-page":"D377","DOI":"10.1093\/nar\/gks1118","article-title":"Panther in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees","volume":"41","author":"Mi","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046688","article-title":"Predicting the functional effect of aminoacid substitutions and indels","volume":"7","author":"Choi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib20","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/bioinformatics\/btl423","article-title":"Predicting the insurgence of human genetic diseases associated to single point protein mutations with Support Vector Machines and evolutionary information","volume":"22","author":"Capriotti","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2105-7-166","article-title":"SNPs3D: candidate gene and SNP selection for association studies","volume":"7","author":"Yue","year":"2006","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib22","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/bioinformatics\/bti486","article-title":"PMUT: a web-based tool for the annotation of pathological mutations on proteins","volume":"21","author":"Ferrer-Costa","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib24","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1093\/nar\/gkr407","article-title":"Predicting the functional impact of protein mutations: application to cancer genomics","volume":"39","author":"Reva","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib25","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1093\/nar\/gkp215","article-title":"Human Splicing Finder: an online bioinformatics tool to predict splicing signals","volume":"37","author":"Desmet","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib28","first-page":"11","article-title":"Common and rare gene variants affecting plasma LDL cholesterol","volume":"29","author":"Burnett","year":"2008","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng1145","article-title":"Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid adsorption disorders","volume":"34","author":"Jones","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ymgme.2007.08.120","article-title":"Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein","volume":"93","author":"Charcosset","year":"2008","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.cca.2011.11.020","article-title":"Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation","volume":"413","author":"Mart\u00edn-Campos","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.medcli.2009.03.007","article-title":"Clinical and genetic heterogeneity in hypobetalipoproteinemia","volume":"133","author":"Pocovi","year":"2009","journal-title":"Med. Clin. Barcelona"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.gene.2013.08.049","article-title":"Familial hypobetalipoproteinemia: analysis of three Spanish cases with two new mutations in the APOB gene","volume":"531","author":"Martin-Morales","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib34","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/jc.2006-1998","article-title":"Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia","volume":"92","author":"Hooper","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cca.2008.07.025","article-title":"Identification of mutations in the apolipoprotein B-100 gene and in the PCSK9 gene as the cause of hypocholesterolemia","volume":"397","author":"Leren","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib36","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.117.032479","article-title":"Genetics, lifestyle, and low-density lipoprotein cholesterol in young and apparently healthy womwn","volume":"137","author":"Balder","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib37","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jacl.2018.09.002","article-title":"Autosomal dominant hypercholesterolemia in Catalonia: correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical setting","volume":"12","author":"Mart\u00edn-Campos","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.ejhg.5200844","article-title":"Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia","volume":"10","author":"Vakkilainen","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib39","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1161\/ATVBAHA.113.301505","article-title":"Evidence of a polygenic origin of extreme high-density lipoprotein cholesterol levels","volume":"33","author":"Motazacker","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib40","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1373\/clinchem.2007.086496","article-title":"Novel mutation (c.G1124A) in exon 9 of the APOB gene causes aberrant splicing and familial hypobetalipoproteinemia","volume":"53","author":"Homer","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib41","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0022-2275(20)41964-9","article-title":"ApoB gene nonsense and splicing mutations in a compound heterozygote for familial hypobetalipoproteinemia","volume":"32","author":"Huang","year":"1991","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/jmg.2006.046359","article-title":"Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia","volume":"44","author":"Di Leo","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib43","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1093\/nar\/16.17.8361","article-title":"Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia","volume":"16","author":"Collins","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib44","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0026-0495(96)90251-6","article-title":"A new apolipoprotein B truncation (apo B-43.7) in familial hypobetalipoproteinemia: genetic and metabolic studies","volume":"45","author":"Srivastava","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib45","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1136\/jmg.2004.029454","article-title":"High frequency of APOB gene mutations causing familial hypobetalipoproteinaemia in patients of Dutch and Spanish descent","volume":"42","author":"Fouchier","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00431-005-1751-7","article-title":"An atypical case of abetalipoproteinaemia with severe fatty liver in the absence of steatorrhoea or acanthocytosis","volume":"165","author":"Sakamoto","year":"2006","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0021-9150(98)00038-0","article-title":"Genetic variation in the amino-terminal part of apolipoprotein B: studies in hyperlipidemic patients","volume":"138","author":"Ilmonen","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib48","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1034\/j.1399-0004.2002.610207.x","article-title":"The effect of six polymorphisms in the Apolipoprotein B gene on parameters of lipid metabolism in a Danish population","volume":"61","author":"Bentzen","year":"2002","journal-title":"Clin. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005573","article-title":"Parent-of-Origin effects of the APOB gene on adiposity in young adults","volume":"11","author":"Hochner","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib50","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1194\/jlr.P035238","article-title":"Noven gene-by-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol","volume":"54","author":"Kim","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1665-2681(19)31564-9","article-title":"Familial hypobetalipoproteinemia in a hospital survey: genetics, metabolism and non-alcoholic fatty liver disease","volume":"10","author":"Guti\u00e9rrez-Cirlos","year":"2011","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib52","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s004390050651","article-title":"Screening for mutations of the apolipoprotein B gene causing hypocholesterolemia","volume":"102","author":"Leren","year":"1998","journal-title":"Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib53","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.amjcard.2011.06.050","article-title":"Replication of genetic association studies in aortic stenosis in adults","volume":"108","author":"Gaudreault","year":"2011","journal-title":"Am. J. Cardiol."},{"issue":"Suppl 17","key":"10.1016\/j.atherosclerosis.2019.01.036_bib54","first-page":"66","article-title":"An analysis of association between the apolipoprotein B gene EcoR1 polymorphism and ischemic stroke","author":"Mustafina","year":"2006","journal-title":"Zh. Nevrol. Psikhiatr. Im. S S Korsakova"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib55","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ng.628","article-title":"Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia","volume":"42","author":"Johansen","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib56","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1172\/JCI45504","article-title":"The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans","volume":"121","author":"Weissglas-Volkov","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122414","article-title":"IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the Italian general population","volume":"10","author":"Dhyani","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1476-511X-11-83","article-title":"N342S polymorphism is not associated with lipid profile in the Brazilian population","volume":"11","author":"Santos","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib59","doi-asserted-by":"crossref","first-page":"32700","DOI":"10.1038\/srep32700","article-title":"An APOC3 3'UTR variant associated with plasma triglycerides levels and coronary heart disease by creating a functional miR-4271 binding dite","volume":"6","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib60","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1476-511X-12-70","article-title":"Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations","volume":"12","author":"Mayne","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib61","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/humu.20316","article-title":"The c.43_44insCTG variation in PCSK9 is associated with low plasma LDL-cholesterol in a caucasian population","volume":"27","author":"Yue","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib62","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib63","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5001\/omj.2013.11","article-title":"Mutation in the PCSK9 gene in Omani Arab subjects with autosomal dominant hypercholesterolemia and its effect on PCSK9 protein structure","volume":"28","author":"Al-Waili","year":"2013","journal-title":"Oman Med. J."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10038-003-0114-3","article-title":"Genetic variants in PCSK9 affect the colesterol level in Japanese","volume":"49","author":"Shioji","year":"2004","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12881-015-0242-6","article-title":"MTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study","volume":"16","author":"Hsiao","year":"2015","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib66","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/dna.2013.2238","article-title":"MTP -493G>T polymorphism and susceptibility to nonalcoholic fatty liver disease: a meta-analysis","volume":"33","author":"Zheng","year":"2014","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1399-0004.1994.tb04404.x","article-title":"Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia","volume":"46","author":"Xu","year":"1994","journal-title":"Clin. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbadis.2003.11.002","article-title":"Hypobetalipoproteinemia with an apparently recessive inheritamce due to a \"de novo\" mutation of apolipoprotein B","volume":"1688","author":"Lancellotti","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib69","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/sj.ejhg.5201191","article-title":"Are common disease susceptibility alleles the same in outbred and founder populations?","volume":"12","author":"Newman","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.01.036_bib70","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000339761","article-title":"Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis","volume":"6","author":"Lam","year":"2012","journal-title":"Case. Rep. Gastroenterol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019300607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019300607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T18:50:34Z","timestamp":1662922234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019300607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":70,"alternative-id":["S0021915019300607"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.01.036","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}